Page 3 - மைக்கேல் லாங்மயர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மைக்கேல் லாங்மயர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மைக்கேல் லாங்மயர் Today - Breaking & Trending Today

Human to Nonhuman Chimeras Discussion Resurfaces After Monkey Embryos Established to Have Human Cells

(Photo : Photo: Screenshot from Instagram)
Genetic chimerism, also known as a chimera, is a single organism made up of cells with several genotypes. In species, this refers to an organism originating from two or more zygotes. It might include blood cells of various blood types, minor differences in structure (phenotype), and even the possession of both female and male sex organs if the zygotes were of different sexes.
Ethical Discussion
(Photo : Pixabay)
Many scientists have expressed reservations about the procedure, claiming that although the embryos, in this case, were killed after 20 days, others might attempt to continue the research.
They re asking for a general discussion on the consequences of making chimeras that are part human and part nonhuman. ....

Anna Smajdor , Jacob Hanna , Julian Savulescu , Sarah Norcross , University Of Oxford , Oxford Uehiro Centre For Practical Ethics , Lab Test , Progress Educational , Wellcome Centre For Ethics , University Of East Anglia Norwich Medical School , New Method , Microscopy Shows Live Cells , Michael Longmire , Revive Extinct Animals , Germans Did Impossible Thing , Paralyzed Mice Freely Walks , Chimera From Two Combined Embryos , East Anglia , Norwich Medical School , Prof Julian Savulescu , Oxford Uehiro Centre , Practical Ethics , Wellcome Centre , Progress Educational Trust , ஜாகோப் ஹன்னா , சாரா நோர்கிராஸ் ,

Medable Raises $78M in Funding

Medable, Inc., a Palo Alto, Calif.-based provider of a digital platform to decentralize clinical trials, raised $78m in funding.
The round was led by Sapphire Ventures, with participation from new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD, Inc. (Nasdaq:PPD) and Streamlined Ventures.
The company, which has raised more than $217m to date, intends to use the funds to continue enabling broad adoption of digital trials and patient-centric strategies at global scale. Key focus areas include internal initiatives related to ubiquitous research access, patient data fluidity, and intelligent monitoring of patients and clinical trial data. ....

Michelle Longmire , Medable Inc , Ppd Inc , Palo Alto , Sapphire Ventures , Obvious Ventures , மைக்கேல் லாங்மயர் , ப்ட் இன்க் , பாலோ ஆல்டோ , சபையர் முயற்சிகள் , வெளிப்படையானது முயற்சிகள் ,

Medable Raises $78M to Expand Decentralized Clinical Trials Platform for Patient-Centered Drug Development -

What You Should Know:
– Medable, Inc., a Palo Alto, CA-based global platform for decentralized clinical trials today announced $78M in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating the industry’s shift to patient-centered drug development. The funding was led by Sapphire Ventures, along with new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD, Inc., and Streamlined Ventures.
– This is Medable’s third round of funding in less than a year, bringing total capital raised to more than $217 million.
Global Decentralized Clinical Trial Platform
Founded in 2015 by Dr. Michelle Longmire and Tim Smith, Medable’s flexible and modular software platform enables clinical leaders to shift from clinic-centric to patient-centric research strategies. The platform provides a unified experience for patients and clinicians, enabling recruitment, remote screening, el ....

Tim Smith , Michelle Longmire , Medable Inc , Ppd Inc , Drug Development , Medable Raises , Expand Decentralized Clinical Trials Platform , Patient Centered Drug , Should Know , Palo Alto , Sapphire Ventures , Obvious Ventures , நேரம் ஸ்மித் , மைக்கேல் லாங்மயர் , ப்ட் இன்க் , மருந்து வளர்ச்சி , வேண்டும் தெரியும் , பாலோ ஆல்டோ , சபையர் முயற்சிகள் , வெளிப்படையானது முயற்சிகள் ,

Tempo lands $200M for digital fitness studio, Benchling scores $200M for pharma research platform and other digital health fundings

Photo by IronHeart/Getty Images
At-home digital fitness studio Tempo has raised $220 million in its recently closed Series C funding round. SoftBank Vision Fund 2 led the round with additional participation from new investor Steadfast Capital Ventures and returning investors DCM, General Catalyst, Norwest Venture Partners, and Bling Capital.
Tempo plans to use the money to continue enhancing its artificial intelligence and 3D sensor tracking technology. The company’s flagship workout device scans users 30 times per second to guide users through the session while correcting their form when necessary.
Coming less than a year after its $60 million raise, Tempo now has nearly $300 million in funding to date. ....

United States , Palo Alto , Carine Carmy , Patrick Fu , Michelle Longmire , Roy Beveridge , Andreessen Horowitz , Elad Gil , Annie Lamont , Softbank Vision Fund , Schroder Co , Blue Venture Fund , Ypsomed Group , Bank Vision Fund , Steadfast Capital Ventures , General Catalyst , Norwest Venture Partners , Capital Global Equities , Altimeter Capital , Byers Capital , Sequoia Capital Global Equities , Suisse Entrepreneur Capital , Endeavour Vision , Tandem Diabetes Care , Federated Hermes Kaufmann Funds , Kingdon Capital ,

Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development

Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United States , Newry And Mourne , United Kingdom , Palo Alto , City Of , San Francisco , Michelle Longmire , David Hartwig , Parag Vaish , Pamela Tenaerts , Sina Mossayeb , Tina Hoang , Andrea Valente , Medable Inc , Ppd Inc , Patient Advisory Council , Life Sciences Innovation Champion , Clinical Trials Transformation Initiative , Patient Champion Network , Duke University , Sapphire Ventures , Obvious Ventures , Tina Hoang To , Chief Scientific Officer , Chief Product Officer , Chief Design Officer ,